Home — Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM-075 for AML Trial

Trovagene Announces Manufacturing Agreement with NerPharMa for Supply of PCM-075 for AML Trial

San Diego, 29.06.2017

Trovagene, Inc. (NASDAQ: TROV), a precision medicine biotechnology company, today announced it has executed a supplier agreement with NerPharMa, S.r.l., a pharmaceutical manufacturing company and a subsidiary of Nerviano Medical Sciences S.r.l., in Milan, Italy, to manufacture drug product for PCM-075.

Read